XPH vs PJP: Which Pharma ETF Offers Better Value
State Street's lower costs appeal to buy-and-hold investors, while Invesco's concentrated portfolio and lower volatility suit risk-averse income seekers.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.